Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
2 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Addition of lenalidomide to rituximab, ifosfamide, carboplatin, etoposide (RICER) in first-relapse/primary refractory diffuse large B-cell lymphoma.
Br J Haematol. 2014 Jul;166(1):77-83. doi: 10.1111/bjh.12846. Epub 2014 Mar 25.
Br J Haematol. 2014.
PMID: 24661044
Free PMC article.
Clinical Trial.
A phase I/II study of the pan Bcl-2 inhibitor obatoclax mesylate plus bortezomib for relapsed or refractory mantle cell lymphoma.
Goy A, Hernandez-Ilzaliturri FJ, Kahl B, Ford P, Protomastro E, Berger M.
Goy A, et al.
Leuk Lymphoma. 2014 Dec;55(12):2761-8. doi: 10.3109/10428194.2014.907891. Epub 2014 May 6.
Leuk Lymphoma. 2014.
PMID: 24679008
Free PMC article.
Clinical Trial.
Item in Clipboard
Cite
Cite